Overview
Pamela S Douglas MD is the Ursula Geller Professor of Research in Cardiovascular Diseases in the Department of Medicine at Duke University and Director of the Multimodality Imaging Program at Duke Clinical Research Institute. During her 30+ years of experience she has led several landmark multicenter government studies and pivotal industry clinical trials along with outcomes research studies. She is renowned for her scientific and policy work in improving the quality and appropriateness of imaging in clinical care, clinical trials and registries and through development and dissemination of national standards for imaging utilization, informatics and analysis. She has been among the pioneers in a number of areas including heart disease in women, sports cardiology, and cardio-oncology. Dr. Douglas’ wealth of experience includes authorship of over 400 peer reviewed manuscripts and 30 practice guidelines, and service as the President of the American College of Cardiology, President of the American Society of Echocardiography, and Chief of Cardiology at both the University of Wisconsin and Duke University. She has also previously served on the faculties of the University of Pennsylvania and Harvard University. She currently serves on the External Advisory Council of the National Heart, Lung and Blood Institute and the Scientific Advisory Board of the Patient Advocate Foundation.
Current Appointments & Affiliations
Recent Publications
Association between polysocial risk score and CVH among women of reproductive age in the SAFE HEART study: An American Heart Association Research Goes Red Initiative.
Journal Article Curr Probl Cardiol · March 2025 BACKGROUND: To assess the association between polysocial risk factors and cardiovascular health (CVH) among women of reproductive age. METHODS: Our cross-sectional analysis included women of reproductive age (18-44 years) from community settings and the Am ... Full text Link to item CitePitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.
Journal Article Clin Infect Dis · February 24, 2025 BACKGROUND: Little is known about the potential benefits or harms of statins on physical function among people with human immunodeficiency virus (PWH). METHODS: REPRIEVE was a double-blind randomized controlled trial evaluating pitavastatin for primary pre ... Full text Link to item CiteClinical likelihood models calibrated against observed obstructive coronary artery disease on computed tomography angiography.
Journal Article Eur Heart J Cardiovasc Imaging · February 7, 2025 AIMS: Models predicting the likelihood of obstructive coronary artery disease (CAD) on invasive coronary angiography (ICA) exist. However, as stable patients with new-onset chest pain frequently have lower clinical likelihood and preferably undergo index t ... Full text Link to item CiteRecent Grants
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
ResearchCo Investigator · Awarded by NYU Langone Medical Center · 2023 - 2028Pericoronary adipose tissue density a novel CT-derived marker of local inflammation and coronary artery disease in patients living with HIV
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2023 - 2027Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN)
ResearchCo Investigator · Awarded by Aga Khan University · 2021 - 2026View All Grants